youtube_live
Q2 2027 earnings • released • EPS miss -5.45% • Revenue beat +2.76%
See resultschevron_right
CONCORDBIO:NSE
Concord Biotech Ltd
₹1,246.00
arrow_upward
+1.25%(+15.40) 1D
Oct 30, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹1,224.30
High
₹1,272.40
Low
₹1,215.10
Mkt. cap
130.35B
Avg. vol.
137.28K
Volume
103.69K
Dividend
0.61%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
46.24
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.95
No. of employees
2K
Open
₹1,224.30
High
₹1,272.40
Low
₹1,215.10
Mkt. cap
130.35B
Avg. vol.
137.28K
Volume
103.69K
Dividend
0.61%
Quarterly dividend
₹1.89
Ex-dividend date
Jul 24, 2026
P/E ratio
46.24
52-wk high
₹1,615.00
52-wk low
₹987.00
EPS
₹26.95
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Concord Biotech Ltd (NSE:CONCORDBIO) (Q2 2027) Earnings Call Highlights: 25% Revenue Surge, ...
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd